Carcinoma, Ductal, Breast clinical trials
The registry lists 86 studies for Carcinoma, Ductal, Breast across more than 10 countries. 7 are recruiting or about to start. 36 of them are mainly about Carcinoma, Ductal, Breast (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05.
Get an email when these change. Save the Carcinoma, Ductal, Breast studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
German Breast Group (4) · RenJi Hospital (4) · City of Hope Medical Center (4) · Intarcia Therapeutics (3) · Alliance for Clinical Trials in Oncology (3) · Case Comprehensive Cancer Center (3) · Rutgers, The State University of New Jersey (2) · NSABP Foundation Inc (2)
What is being tested here
Drugs under test in Carcinoma, Ductal, Breast studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Paclitaxel | 1 | 3 | 7 |
| Cisplatin | 1 | 2 | 3 |
| Ribociclib | 1 | 0 | 1 |
| Huaier Extract Granule | 1 | 0 | 1 |
| Carboplatin | 0 | 2 | 5 |
| Letrozole | 0 | 4 | 5 |
| Trastuzumab | 0 | 0 | 3 |
| Cyclophosphamide | 0 | 0 | 3 |
| Atamestane | 0 | 3 | 3 |
| Toremifene | 0 | 3 | 3 |
Drug classes tested here Antimitotic agents 1 open · Aromatase inhibitors 7 · SERMs 5 · Alkylating agents 3
Coming up
6studies finish main data collection within a year2 of them phase 3
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 6, phase 3 first
- Apr 2027Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery · Phase 3 · Alliance for Clinical Trials in Oncology
- Aug 2027Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women · Phase 3 · RenJi Hospital
- Dec 2026Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma · Stanford University
- Jul 2027Radiation Therapy in Treating Women With Early Stage Breast Cancer · Rutgers, The State University of New Jersey
- Jul 2027A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue · Memorial Sloan Kettering Cancer Center
- Aug 2027Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer · Memorial Sloan Kettering Cancer Center
Who these studies take
Of the 7 Carcinoma, Ductal, Breast studies recruiting now, 5 (71%) set no upper age limit and 2 (29%) stop at 75 or younger. 0 (0%) take children under 18. 3 (43%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 6 (86%) | 4 (57%) |
| 30 | 6 (86%) | 4 (57%) |
| 40 | 6 (86%) | 4 (57%) |
| 50 | 7 (100%) | 4 (57%) |
| 65 | 7 (100%) | 4 (57%) |
| 75 | 5 (71%) | 3 (43%) |
| 85 | 5 (71%) | 3 (43%) |
Across all 86 studies, recruiting or not: 16% stop at 75 or younger and 3% at 65; 8% take children; 78% are for women only and 0% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 86. Browse all 86 → or search them.
- Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerRecruitingNCT07214532Not applicable1 country
- Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal CarcinomaRecruitingNCT03909282Not applicable1 country
- Study of 3-Day Partial Breast Radiation Therapy in Women With Breast CancerRecruitingNCT04084730Phase 21 country
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueRecruitingNCT05837767Not applicable1 country
- Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk WomenRecruitingNCT03201861Phase 31 country
- Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast CancerRecruitingNCT04790305Phase 41 country
- Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast CancerRecruitingNCT061582171 country
- Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic AcidTerminatedNCT01409811Not applicable1 country
- Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast DiseaseCompletedNCT008985081 country
- Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast CancerActive, not recruitingNCT00295893Phase 21 country
- G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast CancerCompletedNCT03455270Phase 17 countries
- BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast CancerCompletedNCT01791478Phase 11 country
- Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing SurgeryActive, not recruitingNCT01953588Phase 32 countries
- LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast CancerCompletedNCT05900986Phase 1/21 country
- 3-Dimensional Conformal Radiation Therapy or Internal Radiation Therapy After Breast-Conserving Surgery in Treating Women With Stage I or Stage II Breast CancerTerminatedNCT00802711Not applicable1 country
- Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast CancerCompletedNCT03947151Phase 21 country
- Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast CancerCompletedNCT02779855Phase 1/21 country
- Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast CancerActive, not recruitingNCT00616967Phase 21 country
- Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast CancerActive, not recruitingNCT03414970Phase 32 countries
- Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast CancerCompletedNCT02186470Not applicable1 country
- Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation TherapyCompletedNCT01819233Not applicable1 country
- Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)WithdrawnNCT01960803Not applicable1 country
- Radiation Therapy During Surgery in Treating Older Women With Invasive Breast CancerCompletedNCT00182728Not applicable1 country
- Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast CancerCompletedNCT017064321 country
- Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1CompletedNCT02620280Phase 37 countries
- Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer PatientsActive, not recruitingNCT02221999Phase 2/31 country
- Radiation Therapy in Treating Women With Early Stage Breast CancerActive, not recruitingNCT00909909Phase 21 country
- Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In SituTerminatedNCT00002934Phase 22 countries
- Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast CancerCompletedNCT00026286Phase 31 country
- Xoft® Intraoperative Radiotherapy (IORT) for Patients With Early-Stage Breast CancerTerminatedNCT040884351 country
- Accelerated Radiation Therapy After Surgery in Treating Patients With Breast CancerCompletedNCT01417286Phase 21 country
- Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the BreastStatus unknownNCT00470236Not applicable11 countries
- G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerStatus unknownNCT02983071Phase 1/24 countries
- Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph NodesCompletedNCT00433589Phase 31 country
- Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast CancerCompletedNCT00694577Not applicable1 country
- Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving SurgeryCompletedNCT01082211Phase 22 countries
- Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle BiopsyCompletedNCT04498611Not applicable1 country
- Living Well After Breast SurgeryCompletedNCT03834532Not applicable1 country
- Efficacy of Magnetic Resonance-guided High Intensity Focused Ultrasound for the Ablation of Breast CancerTerminatedNCT03560102Not applicable1 country
- Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing SurgeryCompletedNCT03113825Phase 21 country
- Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast CancerStatus unknownNCT03749850Phase 11 country
- Denosumab as an add-on Neoadjuvant Treatment (GeparX)CompletedNCT02682693Phase 21 country
- Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of LumpectomyCompletedNCT02576106Not applicable1 country
- Radiation Therapy in Treating Patients With Recurrent Breast CancerCompletedNCT00945061Not applicable1 country
- Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto)CompletedNCT01583426Phase 31 country
- Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast CancerCompletedNCT00599989Not applicable1 country
- Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant ChemotherapyStatus unknownNCT02879513Phase 31 country
- Broccoli Sprout Extract in Treating Patients With Breast CancerCompletedNCT01753908Early Phase 11 country
- Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast CancerTerminatedNCT01891357Phase 21 country
- Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast CancerWithdrawnNCT03523299Not applicable